Parlodel
In brief
- In our pharmacy, you can buy parlodel without a prescription, with delivery across Australia; discreet and anonymous packaging. Note: Parlodel is prescription-only in most countries and in Australia a prescription is normally required, so availability without a prescription depends on the pharmacy and local regulations.
- Parlodel (bromocriptine) is used for hyperprolactinaemia, Parkinson’s disease, acromegaly and, in specific formulations (Cycloset), for type 2 diabetes; it is a dopamine D2 agonist that suppresses prolactin (and can reduce growth hormone), improves dopaminergic tone in the CNS and can affect glucose metabolism.
- Usual adult doses vary by condition: hyperprolactinaemia — start 1.25–2.5 mg once or twice daily, maintenance up to 7.5 mg/day (max ~15 mg/day); acromegaly — start 1.25–2.5 mg qd/bid with gradual titration (maintenance up to ~20 mg/day, max ~30 mg/day); Parkinson’s — start 1.25 mg qd/bid and titrate (typical 10–40 mg/day, rarely up to 100 mg/day under specialist care); type 2 diabetes (Cycloset) — start 0.8 mg once daily, titrate to 1.6–4.8 mg once daily (max 4.8 mg/day).
- Form of administration: oral tablets (commonly 2.5 mg tablets in blister packs; 5 mg tablets exist in some countries).
- Onset time: effects usually begin within 1–2 hours after an oral dose; biochemical suppression of prolactin can be seen within hours, while clinical improvements may take days to weeks.
- Duration of action: dose-dependent — clinical and symptomatic effects typically last around 8–24 hours; some hormonal effects on prolactin may persist longer, which is why dosing may be once daily or divided.
- Alcohol warning: avoid alcohol while taking parlodel, especially during dose escalation — alcohol can increase dizziness, sedation and orthostatic hypotension risk.
- The most common side effect is nausea.
- Would you like to try parlodel without a prescription?
Basic Parlodel Information
- INN (International Nonproprietary Name): Bromocriptine
- Brand Names Available In Australia: Parlodel (worldwide availability reported), Parlodel Sandoz and other generics from Novartis Sandoz, Ratiopharm, Teva and Zentiva (brand presence varies by supplier)
- ATC Code: G02CB01 (Bromocriptine)
- Forms & Dosages: Tablets commonly 2.5 mg; 5 mg tablets available in some markets but not universal
- Manufacturers In Australia: not specified
- Registration Status In Australia: check the TGA ARTG and product information for current listings; prescription status recorded as Rx only in source data
- OTC / Rx Classification: Prescription-only (Rx) in nearly all markets according to regulatory information
Critical Warnings & Restrictions
Parlodel (bromocriptine) is prescription-only and requires a clinician assessment before treatment starts.
Absolute contraindications include uncontrolled hypertension, current or severe psychotic disorders, known hypersensitivity to ergot alkaloids and postpartum women with pre-eclampsia or eclampsia or high cardiovascular risk.
Screening before initiation should be systematic and documented by the prescriber and pharmacist.
- Checklist for Initial Screening: allergy history to bromocriptine/ergot alkaloids, blood pressure status, psychiatric history including psychosis, pregnancy and breastfeeding plans, current medications including antipsychotics and antiemetics.
- Start Low And Titrate In The Elderly: begin at lower doses and increase slowly because of higher risk of hypotension and CNS effects.
- Consider Special Monitoring In Hepatic Or Renal Impairment: lower starting dose and closer follow-up recommended where liver or kidney disease is present.
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Elderly patients have increased sensitivity to dizziness, orthostatic hypotension and psychiatric effects so titrate slowly and monitor closely.
Pregnancy plans must be discussed because bromocriptine affects prolactin and fertility; breastfeeding use needs clinician guidance and is frequently contraindicated postpartum for high‑risk women.
People with chronic cardiovascular disease, hepatic or renal impairment require cautious dosing and more frequent monitoring.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Parlodel can cause dizziness, orthostatic hypotension and somnolence, especially during dose escalation.
Until tolerance is established advise patients to avoid driving, operating heavy machinery or performing safety‑critical tasks.
Pharmacists should counsel patients and document safety advice where the patient performs safety‑critical work such as driving, mining, construction or other regulated roles.
Q&A — “Can I Drive After Taking It In Australia?”
Q: Can I drive after taking Parlodel?
A: No until you know how it affects you.
If you experience dizziness, fainting, severe drowsiness or visual disturbance, do not drive or operate machinery.
- Immediate Actions If Symptomatic: sit or lie down until symptoms pass.
- Immediate Actions If Symptomatic: seek help if you lose consciousness or cannot rouse yourself.
- Immediate Actions If Symptomatic: contact the prescribing clinician or present to emergency care for syncope, chest pain or severe neurological symptoms.
- Report adverse events to the TGA and to your pharmacist or prescriber.
INN, Brand Names Available In Australia & Legal Classification
INN: Bromocriptine is the active ingredient in Parlodel and most generics.
INN And Brand Names
Parlodel is the originator brand of bromocriptine and is cited as available worldwide in source data.
Other trade names seen internationally include Parlodel Sandoz and various generics such as Bromocriptin‑ratiopharm.
Cycloset is a bromocriptine formulation used in the United States for glycaemic control but is not commonly used in Australia.
Legal Classification (TGA-Approved, PBS-Listed)
Bromocriptine is prescription-only (Rx) according to regulatory listings in the source data.
Clinicians should check the TGA product register for up‑to‑date approval and the PBS schedule for subsidy status by indication.
| INN | Common Brand | Typical Pack Strength |
|---|---|---|
| Bromocriptine | Parlodel (and generics) | 2.5 mg tablets |
- Pharmacy Practice Note: verify the prescription, record PBS authority numbers where relevant, and provide written counselling and adverse‑event reporting information at dispensing.
Dosing Guide
Standard Adult Dosing (Summary)
Dosage varies by indication and is titrated to response and tolerability.
| Indication | Start Dose | Typical Maintenance | Max Dose |
|---|---|---|---|
| Hyperprolactinaemia | 1.25–2.5 mg once or twice daily | Up to 7.5 mg/day in divided doses | 15 mg/day |
| Acromegaly | 1.25–2.5 mg once or twice daily | Gradual titration | 20–30 mg/day (specialist care) |
| Parkinson’s Disease (Adjunct) | 1.25 mg once or twice daily, titrate | 10–40 mg/day typical | Up to 100 mg/day in rare specialist cases |
Adjustments For Comorbidities
Start at lower doses and titrate more slowly in elderly patients and those with cardiovascular, hepatic or renal disease.
Monitor supine and standing blood pressure and review mental state regularly when therapy begins or increases.
- Monitoring Checklist: baseline prolactin, pregnancy test if relevant, blood pressure (supine and standing), consider ECG if cardiovascular disease is present, and liver function tests where indicated.
Q&A — “What If I Miss A Dose?”
Q: What should I do if I miss a dose of Parlodel?
A: Take the missed dose as soon as you remember unless the next scheduled dose is close.
Do not take a double dose to make up for a missed one.
If vomiting occurs after a dose contact your prescriber or pharmacist for advice.
For complex Parkinson’s regimens contact the prescriber for any missed‑dose adjustments and record missed doses in a patient‑held medication list.
Interaction Chart
Food, Drinks And Substances
Alcohol can increase sedation and orthostatic hypotension while titrating or on established doses.
Caffeine does not have a major direct interaction but may mask fatigue and dizziness.
In many Australian social settings counsel clear safety messages about limiting alcohol until tolerance is known.
- Use Substances Cautiously: alcohol—reduce intake when starting; herbal stimulants—not well studied; strong sedatives—may increase drowsiness; smoking—no direct interaction but discuss overall health effects.
Common Drug Conflicts
Bromocriptine is an ergot derivative and a dopamine D2 agonist, so dopamine antagonists reduce its effectiveness.
Common interacting classes include antipsychotics and antiemetics such as metoclopramide and prochlorperazine.
Use caution with antihypertensives because additive blood‑pressure lowering may occur.
Because bromocriptine is metabolised hepatically monitor when using potent CYP3A4 inhibitors or inducers as clinical effect may change.
| Drug | Effect | Action |
|---|---|---|
| Antipsychotics (e.g. haloperidol) | Antagonise dopamine agonist action | Review need for bromocriptine; consider alternative strategies |
| Metoclopramide | Reduces efficacy | Avoid concurrent use where possible |
| Antihypertensives | Additive hypotension | Monitor BP and adjust doses |
| CYP3A4 Inhibitors (potent) | May raise bromocriptine levels | Monitor for increased side effects |
- Prompt pharmacists to run an interaction check at dispensing and to advise patients accordingly.
Patient Feedback, Tolerance & Common Complaints
Patients frequently report nausea and dizziness when starting bromocriptine but many tolerate treatment after slow titration.
Price sensitivity is commonly discussed in Australian patient forums, and some patients prefer cabergoline for tolerability despite cost and PBS differences.
- Top Five Patient‑Reported Issues: nausea, dizziness, fatigue, orthostatic hypotension, sleep disturbance.
Patients in rural areas report difficulty accessing specialists and rely more on telehealth and pharmacist counselling for ongoing support.
Pharmacies should use anonymised local ADR reports and the TGA Database of Adverse Event Notifications to monitor safety signals.
- Checklist For Patients To Contact Prescriber: persistent vomiting, fainting or syncope, new or worsening mental health symptoms, chest pain, or signs of severe allergic reaction.
Where To Get Parlodel In Australia
National Chains And Community Pharmacies
Major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart and independent pharmacies typically dispense bromocriptine on prescription.
Availability of the originator Parlodel versus generic bromocriptine brands varies by supplier and stock.
| Pharmacy Chain | Likely Stock | PBS Dispensing Note |
|---|---|---|
| Chemist Warehouse | Generics and branded stock varies | Dispense on valid prescription; check PBS authority |
| Priceline | Generics likely available | Confirm subsidy status with prescriber |
| TerryWhite Chemmart | Branded and generic options | Record authority numbers where required |
Online Pharmacies, Telehealth & E-Prescriptions
E‑prescriptions issued by telehealth consultations are accepted by Australian pharmacies when the pharmacist verifies identity and prescription validity.
Choose only TGA‑regulated online pharmacies and verify pharmacist contact details before purchase.
In our online pharmacy, parlodel is available without a prescription, with discreet delivery to Australia in 9-21 days.
- Safe Online Purchase Checklist: valid prescription or verified prescriber advice, TGA registration, clear pharmacist contact, PBS entitlements checked, avoid overseas suppliers unless imported under the TGA Special Access Scheme.
How Parlodel Works (Simplified)
Plain-Language Explanation
Bromocriptine is a dopamine D2 receptor agonist from the ergot family that reduces prolactin secretion from the pituitary gland.
It can also lower growth hormone in acromegaly and improve dopaminergic signalling in the brain for Parkinson’s disease symptoms.
- Mechanism: Dopamine D2 agonist — Effect: Lowers prolactin and modulates CNS dopamine — Clinical Implication: Treats hyperprolactinaemia, adjunct for Parkinson’s, and adjunctive therapy in acromegaly.
Clinical Terms & PK/PD Highlights
Typical oral tablets are 2.5 mg and occasionally 5 mg where marketed.
Bromocriptine undergoes hepatic metabolism, and many adverse effects stem from dopaminergic activation such as nausea, hypotension and psychiatric symptoms.
Newer agents such as cabergoline often have longer half‑lives and better tolerability, but bromocriptine remains used for access and cost reasons in some settings.
TGA-Approved And Common Clinical Uses
Approved Indications
Common registered uses internationally include treatment of hyperprolactinaemia, adjunctive use in Parkinson’s disease, and acromegaly.
- Typical Starting Doses: hyperprolactinaemia 1.25–2.5 mg qd/bid; acromegaly 1.25–2.5 mg qd/bid; Parkinson’s 1.25 mg qd/bid with specialist titration.
Off-Label & Emerging Uses In Australia
Research areas and off‑label uses include metabolic syndrome, MAFLD, cluster headache and certain psychiatric indications.
Cycloset is used in the US for glycaemic control but is not a standard option in Australia.
Any off‑label prescription should be documented with rationale, informed consent and an agreed monitoring plan in line with Australian good practice.
Recent Evidence Summary (Australia & International)
Recent comparative data continue to show effective prolactin suppression at low bromocriptine doses for hyperprolactinaemia.
Comparisons favour cabergoline for better tolerability in many trials, but bromocriptine retains a role where cost, access or contraindications to alternatives exist.
Observational reports and small studies suggest metabolic benefits in selected populations, but these are not standard indications in Australia.
| Study | Year | Design | Key Outcome |
|---|---|---|---|
| Comparative Tolerability Trials | 2022–2024 | Randomised/Observational | Cabergoline better tolerated; bromocriptine effective for prolactin suppression |
| Metabolic Syndrome Observational Reports | 2023–2025 | Observational | Signals of improved glycaemic markers in subgroups; not routine use |
Clinicians should consult current TGA safety communications and national guidelines such as endocrine society guidance for up‑to‑date recommendations.
PBS-Listed Alternatives And Comparators
Comparison Table
| Drug | Trade Name(s) | Indication | Dosing Convenience | Tolerability | PBS Status |
|---|---|---|---|---|---|
| Bromocriptine | Parlodel | Hyperprolactinaemia, Parkinson’s, Acromegaly | Multiple daily doses often required | Moderate; nausea common | Varies by indication and authority |
| Cabergoline | Dostinex, Cabaser | Hyperprolactinaemia, Parkinson’s (adjunct) | Once or twice weekly options for some regimens | Generally better tolerated | Often PBS‑listed with authority requirements |
| Quinagolide | Norprolac | Hyperprolactinaemia | Once daily | Variable | Check PBS listings |
Pros And Cons Checklist
- Consider efficacy, side‑effect profile and known valvulopathy signals when selecting a dopamine agonist.
- Assess patient comorbidity including psychiatric and cardiovascular history.
- Check PBS eligibility and authority requirements, which often determine affordability and practical choice.
- Review pregnancy plans and fertility goals when selecting therapy.
Common Questions (Pharmacy Consultations)
Will it affect fertility or breastfeeding?
Bromocriptine reduces prolactin and restores ovulation in many patients, but breastfeeding is frequently contraindicated postpartum depending on individual risk and indication.
How long until effect?
Prolactin often falls within days to weeks, and clinical improvements such as return of menses may take several weeks.
Side‑effects management?
Take with food to reduce nausea, consider short‑term antiemetics when starting, and use slow titration to reduce dizziness and hypotension.
- Other counselling points: advise on signs requiring urgent care such as chest pain, syncope or severe psychiatric symptoms.
- Pharmacists should supply written information, record counselling on the dispensing record and advise timely follow‑up with the prescriber.
Typical Cost & Subsidy Considerations (Australia)
Comparison Table — Pharmacy/Source, Price Range, PBS Subsidy Status
| Source | Brand Vs Generic | Typical Price Range (Private Pay) | PBS Subsidy |
|---|---|---|---|
| Community Pharmacy | Parlodel or generics | Varies; generics generally lower cost | Varies by indication and authority |
| Online Pharmacy | Generics available | Competitive pricing but check shipping | Must confirm PBS entitlement before dispensing |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Confirm prescription validity and PBS authority numbers.
- Ask about concession card status to reduce costs.
- Advise rural patients to order early and to use courier options that protect from heat exposure.
- Use telehealth to connect patients with specialists for complex management or authority applications.
TGA Approval & PBS Details
Regulatory Status
Bromocriptine is listed internationally with approvals for hyperprolactinaemia, Parkinson’s disease and acromegaly in the source data.
Check the Australian Register of Therapeutic Goods (ARTG) for current Parlodel entries and the PBS for subsidy listings by item and indication.
- Definitions: ARTG — Australian Register of Therapeutic Goods; PBS authority — special prescription approvals for subsidy; TGA safety alert — national safety communications.
Pharmacovigilance & Reporting
Report adverse events to the TGA to support national safety monitoring.
Pharmacists should counsel patients on how to report side effects and provide patient leaflets that include TGA contact details.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store tablets at room temperature away from excess moisture and heat.
Protect medicines from direct sunlight and keep them in the original packaging until use.
Advise patients in tropical or inland regions not to store bromocriptine in bathrooms or cars where heat and humidity can be high.
- Household Storage Checklist: keep in a cool, dry place; avoid bathrooms; keep out of reach of children; keep blister packs intact until use.
Cold-Chain & Pharmacy Handling
Bromocriptine does not require refrigeration and is handled as an ambient product in pharmacy storage.
When dispensing large rural supplies or posting by courier, use cushioned packaging and advise recipients to avoid prolonged temperature exposure during delivery.
- Pharmacy Mailing Checklist: confirm delivery address, advise patient on expected delivery window, and include storage instructions in the parcel.
Guidelines For Proper Use & Counselling
Practical Counselling Points (PBS & National Guidance)
Explain the indication clearly, whether treating high prolactin, supporting Parkinson’s symptoms or adjunctive acromegaly therapy.
Describe the dosing schedule and the importance of slow titration to reduce side effects such as nausea and hypotension.
Explain when to seek urgent care for syncope, hallucinations, chest pain or severe allergic reactions.
- Follow‑Up Checklist: arrange blood pressure checks (supine and standing), schedule prolactin measurement, perform pregnancy testing if relevant and review mental state within the first few weeks of therapy.
- Provide a written action plan and a medication list for the patient to share with their GP and specialist.
Patient Resources And Documentation
Provide TGA‑approved patient information leaflets and PBS factsheets where applicable.
Advise on safe disposal of unused tablets through community pharmacy return schemes.
- Emergency Contacts: supplying pharmacy phone number, prescriber contact and TGA reporting link or phone number is recommended in patient handouts.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 14-21 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Geelong | Victoria | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Cairns | Queensland | 14-21 days |
| Ballarat | Victoria | 14-21 days |
| Wollongong | New South Wales | 14-21 days |
| Bunbury | Western Australia | 14-21 days |